Sumitomo Mitsui DS Asset Management Company Ltd Has $343,000 Stock Position in Revvity Inc. $RVTY

Sumitomo Mitsui DS Asset Management Company Ltd lowered its holdings in Revvity Inc. (NYSE:RVTY) by 73.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,542 shares of the company’s stock after selling 9,864 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Revvity were worth $343,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in RVTY. EdgePoint Investment Group Inc. grew its holdings in Revvity by 26.3% in the 3rd quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock valued at $751,536,000 after buying an additional 1,784,620 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in Revvity by 127.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock valued at $171,921,000 after buying an additional 980,142 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in Revvity by 39.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock valued at $186,307,000 after buying an additional 596,436 shares during the last quarter. Neuberger Berman Group LLC grew its holdings in Revvity by 4,598.9% in the 3rd quarter. Neuberger Berman Group LLC now owns 460,447 shares of the company’s stock valued at $40,358,000 after buying an additional 450,648 shares during the last quarter. Finally, Diamond Hill Capital Management Inc. bought a new stake in shares of Revvity in the 3rd quarter worth approximately $35,206,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Price Performance

Revvity stock opened at $101.32 on Monday. The business has a 50 day simple moving average of $90.30 and a 200 day simple moving average of $96.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.72 and a quick ratio of 1.41. Revvity Inc. has a one year low of $81.22 and a one year high of $118.30. The company has a market capitalization of $11.33 billion, a PE ratio of 48.48, a price-to-earnings-growth ratio of 2.18 and a beta of 1.05.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The firm had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. During the same quarter in the previous year, the company posted $1.01 EPS. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, sell-side analysts forecast that Revvity Inc. will post 5.33 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be given a $0.07 dividend. The ex-dividend date is Friday, July 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity’s payout ratio is presently 13.40%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on RVTY shares. Wall Street Zen downgraded Revvity from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. JPMorgan Chase & Co. cut their target price on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Robert W. Baird set a $117.00 target price on Revvity in a research report on Wednesday. Wells Fargo & Company raised their target price on Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Finally, Weiss Ratings downgraded Revvity from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, March 18th. Four equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $107.73.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.